ArticlePloS one2017
Incidence, predictors and severity of adverse events among whole blood donors.
Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- What is the impact of whole-blood donation frequency on donor health? A systematic review.Vox sanguinis · 2026Pooled it
- Risk factors for vasovagal reactions in blood donors: A systematic review and meta-analysis.Transfusion · 2025Pooled it
- Motives and barriers to blood donation among adults aged over 50 years: A qualitative analysis.Transfusion medicine (Oxford, England) · 2026Article
- Blood donation criteria in Australia: Population knowledge, misperceptions, and impact on donation intent.Transfusion · 2025Article
- Rethinking the role of older donors in a sustainable blood supply.Transfusion · 2025Article
- Predicting vasovagal reactions to needles with anticipatory facial temperature profiles.Scientific reports · 2023Article
- Safe Blood Donation from Donors Using Antihypertensive Medication. A Multi-Center Retrospective Quality Study from South-East Norway.Journal of blood medicine · 2023Article
- Machine learning-based prediction of fainting during blood donations using donor properties and weather data as features.BMC medical informatics and decision making · 2022Article
- Analysis of influencing factors of serum total protein and serum calcium content in plasma donors.PeerJ · 2022Article
- Incidence and severity of adverse events among platelet donors: A three-year retrospective study.Medicine · 2020Article
- Incidence of adverse reaction in blood donation: a systematic review.American journal of blood research · 2020Review
- Joint effects of risk factors on adverse events associated with adult blood donations.Medicine · 2019Article
- Blood donation from 2006 to 2015 in Zhejiang Province, China: annual consecutive cross-sectional studies.BMJ open · 2019Article
- Blood donation and health status based on SF-36: The mediating effect of cognition in blood donation.PloS one · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdverse events have been reported post blood donation. Donors might refrain from donating again due to such events which lowers the blood supply in collection centers.
aimThis study measured the incidence, predictors and severity of adverse events among donors of a single whole blood unit at one of the largest donation centers in Saudi Arabia.
methodsA retrospective cohort was conducted in 2015 to investigate the adverse events immediately post donation. Donor characteristics such as age, blood pressure, hemoglobin level, weight and history of donation were described and tested as potential risk predictors. Eligible blood donors were 18,936/24,634 (76.8%).
resultsIncidence of adverse events found 1.1% (208 donors), of which 0.65% had mild symptoms (chills; nausea; pallor; dizziness; nervousness; headache), while 0.45% had severe symptoms (hypotension; convulsions; syncope; respiratory distress; emesis). Multiple logistic regression showed that, the incidence of adverse events was significantly higher among young age donors <30 years RR[95%CI] = 1.58[1.18-2.12], p < 0.002, higher hemoglobin levels RR[95%CI] = 1.30[1.15-1.46], lower weight donors <75kg RR[95%CI] = 1.71[1.29-2.27], p <0.001 and first time donors RR[95%CI] = 2.21[1.64-2.97], p < 0.001 compared to older age donors ≥30, lower hemoglobin levels, heavier weight donors ≥ 75, and previous donors, respectively. More severe adverse events were observed among older and heavier donors, previous donors, lower hemoglobin levels and hypertensive donors but with no statistical significance.
conclusionYoung blood donors, donors with lower weight and first time donors are at higher risk of contracting adverse events. Higher hemoglobin level is also a potential risk predictor of adverse events post whole blood donation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.